Fingerprint
Dive into the research topics of 'Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer
Shanu Modi, Michael P. DiGiovanna, Zhao Lu, Chaya Moskowitz, Katherine S. Panageas, Catherine Van Poznak, Clifford A. Hudis, Larry Norton, Lee Tan, David F. Stern, Darryl Carter, Andrew D. Seidman
Research output: Contribution to journal › Article › peer-review
38
Scopus
citations